Praecis Pharmaceuticals Inc Sample Contracts

Standard Contracts

AutoNDA by SimpleDocs
6,250,000 Shares(1) Common Stock ($.01 par value)
Underwriting Agreement • February 14th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
WITNESSETH:
License Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
LEASE
Lease • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
JOINT FILING AGREEMENT
Joint Filing Agreement • November 1st, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations

The undersigned hereby agree that the Statement on this Schedule 13G/A, dated November 1, 2001, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.01 per share, of Praecis Pharmaceuticals Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G/A . Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G/A, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

HILL BUILDING Lease to Pharmaceutical Peptides, Inc.
Lease Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
WITNESSETH:
Supply Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Iowa
LEASE AGREEMENT
Lease Agreement • August 14th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
BY AND BETWEEN SYNTHELABO AND
License Agreement • April 3rd, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENT BETWEEN
Confidentiality Agreement • August 12th, 1998 • Praecis Pharmaceuticals Inc
8,000,000 Shares(1) Common Stock ($.01 par value)
Underwriting Agreement • March 28th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreement • January 26th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
BEST PROPERTY FUND, L.P., as Seller and PRAECIS PHARMACEUTICALS INCORPORATED, as Purchaser Property:
Contract of Sale • March 10th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
WARRANT AGREEMENT
Warrant Agreement • November 13th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
by and between
Collaboration and License Agreement • April 3rd, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • New York
TABLE OF CONTENTS -----------------
Stock and Warrant Purchase Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AutoNDA by SimpleDocs
RECITALS
Commercial Supply Agreement • March 19th, 2003 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.2 ACQUISITION AND CONSTRUCTION LOAN AGREEMENT
Acquisition and Construction Loan Agreement • August 14th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
September 16, 2004 Richard W. Wagner, Ph.D.
Severance Agreement • September 21st, 2004 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER among SMITHKLINE BEECHAM CORPORATION, PILGRIM ACQUISITION CORPORATION, and PRAECIS PHARMACEUTICALS INCORPORATED Dated as of December 20, 2006
Merger Agreement • December 21st, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

AGREEMENT AND PLAN OF MERGER, dated as of December 20, 2006 (this “Agreement”), among SMITHKLINE BEECHAM CORPORATION, a Pennsylvania corporation (“Parent”), PILGRIM ACQUISITION CORPORATION, a Delaware corporation and a wholly-owned Subsidiary of Parent (“Purchaser”), and PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation (the “Company”).

COLLABORATION AGREEMENT BETWEEN HUMAN GENOME SCIENCES, INC. AND PRAECIS PHARMACEUTICALS INCORPORATED
Collaboration Agreement • February 8th, 2000 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RIGHTS AGREEMENT
Rights Agreement • January 26th, 2001 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT By and Between SMITHKLINE BEECHAM CORPORATION AND GLAXO GROUP LIMITED AND PRAECIS PHARMACEUTICALS INCORPORATED Dated as of April 7, 2006
Stock Purchase Agreement • August 4th, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of April 7, 2006, by and between SmithKline Beecham Corporation, a corporation organized under the laws of Pennsylvania, having a principal place of business at One Franklin Plaza, 200 N. 16th Street, Philadelphia, Pennsylvania 19102 (“SBC”) and Glaxo Group Limited, a company organized under the laws of England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex, UB6 ONN, United Kingdom (“GGL”, and with SBC collectively, the “Investor” and each sometimes referred to herein as an “Investor”), and PRAECIS PHARMACEUTICALS INCORPORATION (the “Company”), a corporation organized under the laws of Delaware with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451-1420.

AMENDMENT NO. 1 TO RIGHTS AGREEMENT
Rights Agreement • December 21st, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

AMENDMENT NO. 1, dated as of December 20, 2006 (“First Amendment”), to the Rights Agreement (the “Rights Agreement”), January 24, 2001, between PRAECIS PHARMACEUTICALS INCORPORATED, a Delaware corporation (the “Company”) and American Stock Transfer and Trust Company, a New York banking corporation, as rights agent (the “Rights Agent”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!